<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36745687</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7404</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>PLoS genetics</Title><ISOAbbreviation>PLoS Genet</ISOAbbreviation></Journal><ArticleTitle>Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids.</ArticleTitle><Pagination><StartPage>e1010606</StartPage><MedlinePgn>e1010606</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1010606</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgen.1010606</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder caused by progressive loss of motor neurons and there is currently no effective therapy. Cytoplasmic mislocalization and aggregation of TAR DNA-binding protein 43 kDa (TDP-43) within the CNS is a pathological hallmark in sporadic ALS and prion-like propagation of pathogenic TDP-43 is thought to be implicated in disease progression. However, cell-to-cell transmission of pathogenic TDP-43 in the human CNS has not been confirmed experimentally. Here we used induced pluripotent stem cells (iPSCs)-derived cerebral organoids as recipient CNS tissue model that are anatomically relevant human brain. We injected postmortem spinal cord protein extracts individually from three non-ALS or five sporadic ALS patients containing pathogenic TDP-43 into the cerebral organoids to validate the templated propagation and spreading of TDP-43 pathology in human CNS tissue. We first demonstrated that the administration of spinal cord extracts from an ALS patient induced the formation of TDP-43 pathology that progressively spread in a time-dependent manner in cerebral organoids, suggesting that pathogenic TDP-43 from ALS functioned as seeds and propagated cell-to-cell to form de novo TDP-43 pathology. We also reported that the administration of ALS patient-derived protein extracts caused astrocyte proliferation to form astrogliosis in cerebral organoids, reproducing the pathological feature seen in ALS. Moreover, we showed pathogenic TDP-43 induced cellular apoptosis and that TDP-43 pathology correlated with genomic damage due to DNA double-strand breaks. Thus, our results provide evidence that patient-derived pathogenic TDP-43 can mimic the prion-like propagation of TDP-43 pathology in human CNS tissue. Our findings indicate that our assays with human cerebral organoids that replicate ALS pathophysiology have a promising strategy for creating readouts that could be used in future drug discovery efforts against ALS.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Tamaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tamaki</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Jay P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alipour</LastName><ForeName>Paria</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castonguay</LastName><ForeName>Charles-&#xc9;tienne</ForeName><Initials>C&#xc9;</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Boting</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catoire</LastName><ForeName>Helene</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rochefort</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urushitani</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Otsu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonnen</LastName><ForeName>Joshua A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Pathology, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stifani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dion</LastName><ForeName>Patrick A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouleau</LastName><ForeName>Guy A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0001-8403-1418</Identifier><AffiliationInfo><Affiliation>Montreal Neurological Institute-Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>332971</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Genet</MedlineTA><NlmUniqueID>101239074</NlmUniqueID><ISSNLinking>1553-7390</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="Y">Prions</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009940" MajorTopicYN="N">Organoids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>13</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36745687</ArticleId><ArticleId IdType="pmc">PMC9934440</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1010606</ArticleId><ArticleId IdType="pii">PGENETICS-D-22-00831</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al.. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al.. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133. doi: 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, et al.. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40(5):572&#x2013;574. doi: 10.1038/ng.132</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al.. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319(5870):1668&#x2013;1672. doi: 10.1126/science.1154584</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Cleveland DW. Prion-like spread of protein aggregates in neurodegeneration. J Exp Med. 2012;209(5):889&#x2013;893. doi: 10.1084/jem.20120741</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20120741</ArticleId><ArticleId IdType="pmc">PMC3348110</ArticleId><ArticleId IdType="pubmed">22566400</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Lee VM, Trojanowski JQ. Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci. 2015;16(2):109&#x2013;120. doi: 10.1038/nrn3887</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3887</ArticleId><ArticleId IdType="pmc">PMC4312418</ArticleId><ArticleId IdType="pubmed">25588378</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, et al.. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol. 2009;11(7):909&#x2013;913. doi: 10.1038/ncb1901</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1901</ArticleId><ArticleId IdType="pmc">PMC2726961</ArticleId><ArticleId IdType="pubmed">19503072</ArticleId></ArticleIdList></Reference><Reference><Citation>Luk KC, Kehm V, Carroll J, Zhang B, O&#x2019;Brien P, Trojanowski JQ, et al.. Pathological &#x3b1;-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338(6109):949&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3552321</ArticleId><ArticleId IdType="pubmed">23161999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mougenot AL, Bencsik A, Nicot S, Vulin J, Morignat E, Verch&#xe8;re J, et al.. Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated &#x3b1;-synuclein. J Neuropathol Exp Neurol. 2011;70(5):377&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">21487306</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, et al.. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211(4):897&#x2013;911. doi: 10.1083/jcb.201504057</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, et al.. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4(1):124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimonaka S, Nonaka T, Suzuki G, Hisanaga S, Hasegawa M. Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils. J Biol Chem. 2016;291(17):8896&#x2013;8907. doi: 10.1074/jbc.M115.713552</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.713552</ArticleId><ArticleId IdType="pmc">PMC4861459</ArticleId><ArticleId IdType="pubmed">26887947</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, Newcombe J, Troakes C, Simone R, Chen YR, Patani R, et al.. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol Dis. 2016;96:236&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5113659</ArticleId><ArticleId IdType="pubmed">27590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Boutej H, Soucy G, Bareil C, Kumar S, Picher-Martel V, et al.. Transmission of ALS pathogenesis by the cerebrospinal fluid. Acta Neuropathol Commun. 2020;8(1):65. doi: 10.1186/s40478-020-00943-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00943-4</ArticleId><ArticleId IdType="pmc">PMC7206749</ArticleId><ArticleId IdType="pubmed">32381112</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, et al.. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018;9(1):4220. doi: 10.1038/s41467-018-06548-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol. 2012;13(11):713&#x2013;726. doi: 10.1038/nrm3448</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3448</ArticleId><ArticleId IdType="pubmed">23034453</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni M, Rey F, Fantini V, Pansarasa O, Di Giulio AM, Carelli S, et al.. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases. Int J Mol Sci. 2018;19(12):3972. doi: 10.3390/ijms19123972</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19123972</ArticleId><ArticleId IdType="pmc">PMC6321164</ArticleId><ArticleId IdType="pubmed">30544711</ArticleId></ArticleIdList></Reference><Reference><Citation>Chlebanowska P, Tejchman A, Su&#x142;kowski M, Skrzypek K, Majka M. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson&#x2019;s Disease. Int J Mol Sci. 2020;21(3):694. doi: 10.3390/ijms21030694</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21030694</ArticleId><ArticleId IdType="pmc">PMC7037292</ArticleId><ArticleId IdType="pubmed">31973095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghatak S, Dolatabadi N, Trudler D. Mechanisms of hyperexcitability in Alzheimer&#x2019;s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls. Elife. 2019;8:e50333. doi: 10.7554/eLife.50333</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.50333</ArticleId><ArticleId IdType="pmc">PMC6905854</ArticleId><ArticleId IdType="pubmed">31782729</ArticleId></ArticleIdList></Reference><Reference><Citation>Groveman BR, Foliaki ST, Orru CD, Zanusso G, Carroll JA, Race B, et al.. Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun. 2019;7(1):90. doi: 10.1186/s40478-019-0742-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0742-2</ArticleId><ArticleId IdType="pmc">PMC6567389</ArticleId><ArticleId IdType="pubmed">31196223</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al.. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008;64(1):60&#x2013;70. doi: 10.1002/ana.21425</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 2014;15(3):R46. doi: 10.1186/gb-2014-15-3-r46</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2014-15-3-r46</ArticleId><ArticleId IdType="pmc">PMC4053813</ArticleId><ArticleId IdType="pubmed">24580807</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al.. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17(1):122. doi: 10.1186/s13059-016-0974-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-016-0974-4</ArticleId><ArticleId IdType="pmc">PMC4893825</ArticleId><ArticleId IdType="pubmed">27268795</ArticleId></ArticleIdList></Reference><Reference><Citation>Paila U, Chapman BA, Kirchner R, Quinlan AR. GEMINI: integrative exploration of genetic variation and genome annotations. PLoS Comput Biol. 2013;9(7):e1003153. doi: 10.1371/journal.pcbi.1003153</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003153</ArticleId><ArticleId IdType="pmc">PMC3715403</ArticleId><ArticleId IdType="pubmed">23874191</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ, Francioli LC. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434&#x2013;443. doi: 10.1038/s41586-020-2308-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al.. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501(7467):373&#x2013;379. doi: 10.1038/nature12517</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12517</ArticleId><ArticleId IdType="pmc">PMC3817409</ArticleId><ArticleId IdType="pubmed">23995685</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al.. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al.. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM, et al.. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol Neurodegener. 2019;14(1):9. doi: 10.1186/s13024-019-0310-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LR, Duan L, Bowen K, Kalab P, Rothstein JD. C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. Elife. 2020;9:e51685. doi: 10.7554/eLife.51685</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.51685</ArticleId><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ, Mitrea DM, Sarkar M, Freibaum BD, et al.. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell. 2016;167(3):774&#x2013;788 e717. doi: 10.1016/j.cell.2016.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen X, Cai J, Kropf E, Iacovitti L, et al.. Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD. Cell Rep. 2016;17(3):645&#x2013;652. doi: 10.1016/j.celrep.2016.09.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook CN, Wu Y, Odeh HM, Gendron TF, Jansen-West K, Rosso Gd, et al.. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci Transl Med. 2020;12(559):eabb3774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989020</ArticleId><ArticleId IdType="pubmed">32878979</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Jiang J, Garcia SD, Taylor AE, Schulte D, et al.. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135(3):459&#x2013;474. doi: 10.1007/s00401-017-1793-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron. 2014;81(2):229&#x2013;248. doi: 10.1016/j.neuron.2013.12.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.034</ArticleId><ArticleId IdType="pmc">PMC3984950</ArticleId><ArticleId IdType="pubmed">24462092</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke LE, Barres BA. Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci. 2013;14(5):311&#x2013;321. doi: 10.1038/nrn3484</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3484</ArticleId><ArticleId IdType="pmc">PMC4431630</ArticleId><ArticleId IdType="pubmed">23595014</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci Res. 2018;126:31&#x2013;38. doi: 10.1016/j.neures.2017.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy D, Kato T, Kushner PD. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J Neurosci Res. 1994;38(3):336&#x2013;347. doi: 10.1002/jnr.490380312</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490380312</ArticleId><ArticleId IdType="pubmed">7523689</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero EN, Mitra J, Wang H, Rangaswamy S, Hegde PM, Basu P, et al.. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum Mol Genet. 2019;28(15):2459&#x2013;2476. doi: 10.1093/hmg/ddz062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz062</ArticleId><ArticleId IdType="pmc">PMC6659010</ArticleId><ArticleId IdType="pubmed">31067307</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka A, Whelan DR, Jamali MS, Perri E, Shahheydari H, Toth RP, et al.. Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations. Mol Neurodegener. 2020;15(1):51. doi: 10.1186/s13024-020-00386-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00386-4</ArticleId><ArticleId IdType="pmc">PMC7488163</ArticleId><ArticleId IdType="pubmed">32907630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J, Guerrero EN, Hegde PM, Liachko NF, Wang H, Vasquez V, et al.. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc Natl Acad Sci U S A. 2019;116(10):4696&#x2013;4705. doi: 10.1073/pnas.1818415116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139. J Biol Chem. 1998;273(10):5858&#x2013;5868. doi: 10.1074/jbc.273.10.5858</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.10.5858</ArticleId><ArticleId IdType="pubmed">9488723</ArticleId></ArticleIdList></Reference><Reference><Citation>KUO LJ, YANG L-X. &#x3b3;-H2AX&#x2014;A Novel Biomarker for DNA Double-strand Breaks. In Vivo. 2008;22(3):305&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">18610740</ArticleId></ArticleIdList></Reference><Reference><Citation>Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, et al.. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener. 2012;7:42. doi: 10.1186/1750-1326-7-42</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-42</ArticleId><ArticleId IdType="pmc">PMC3483256</ArticleId><ArticleId IdType="pubmed">22920859</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O&#x2019;Neill MA, et al.. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2014;111(9):3620&#x2013;3625. doi: 10.1073/pnas.1312245111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, et al.. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem. 2012;287(6):3842&#x2013;3849. doi: 10.1074/jbc.M111.277061</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.277061</ArticleId><ArticleId IdType="pmc">PMC3281682</ArticleId><ArticleId IdType="pubmed">22057275</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, et al.. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187&#x2013;3201. doi: 10.1093/brain/aww237</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, et al.. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29(9):824&#x2013;828. doi: 10.1038/nbt.1957</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al.. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10(5):615&#x2013;622. doi: 10.1038/nn1876</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al.. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11(3):251&#x2013;253. doi: 10.1038/nn2047</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, Herranz-Martin S, Karyka E, Liao C, Lewis K, Elsayed W, et al.. C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci. 2017;20(9):1225&#x2013;1235. doi: 10.1038/nn.4604</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4604</ArticleId><ArticleId IdType="pmc">PMC5578434</ArticleId><ArticleId IdType="pubmed">28714954</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>